產(chǎn)品名稱 KAT8 regulatory NSL3 Recombinant Protein Antigen from NOVUS BIOLOGICALS, LLC
    產(chǎn)品貨號 NBP2-55131PEP
    產(chǎn)品價格 現(xiàn)貨詢價，電話：010-67529703
    產(chǎn)品規(guī)格 100 ul
    產(chǎn)品品牌 NOVUS BIOLOGICALS, LLC
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameKAT8 regulatory NSL3 Recombinant Protein Antigen
    DescriptionPurity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 27 kDa. The KAT8 regulatory NSL3 Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The KAT8 regulatory NSL3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
    Size100 ul
    Concentrationn/a
    ApplicationsAntibody Competition
    Other NamesFLJ10081, FLJ23799, hypothetical protein LOC55683, KIAA1310, PRTD, Rcd1, Serum inhibited-related protein, SI1, Testis development protein PRTD
    Gene, Accession, CAS #KANSL3, Gene ID: 55683
    Catalog #NBP2-55131PEP
    Price
    Order / More InfoKAT8 regulatory NSL3 Recombinant Protein Antigen from NOVUS BIOLOGICALS, LLC
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>